Monday, July 27, 2015

Teva to Buy Allergan Generics for $40.5 Billion

Teva Pharmaceutical Industries said it would buy Allergan’s generics unit for $40.5 billion in cash and stock in a deal that will vault the Israeli company into the top ranks of global drug makers.

from WSJ.com: US Business http://ift.tt/1JK0kXs
via IFTTT

No comments:

Post a Comment